McKesson fully exits European market
By HME News Staff
Updated 10:09 AM CST, Tue February 3, 2026
IRVING, Texas – McKesson has announced that it has sold its retail and distribution businesses in Norway to NorgesGruppen, a privately-owned retail group. McKesson previously announced that it planned to divest Norway, which is included in its Other segment. The transaction represents the final step in the company’s commitment to fully exit its European operations. The move allows the company to focus strategy and capital allocation on expanding and accelerating its growth platforms within its Oncology and Multispecialty and Biopharma Services segments. McKesson also plans to spin off its Medical-Surgical segment. The company also recently announced that its board of directorshas declared a regular dividend of 82 cents per share of common stock payable on April 1, 2026, to shareholders of record on March 2, 2026.
Comments